Should the UK make participation in clinical trials a default opt-in for NHS patients?

Britain's medical research lags behind the US and Germany, partly due to slow trial recruitment. Some scientists argue an opt-in default could speed up cures, while critics warn it erodes informed consent.

Anoniem stemmen is mogelijk. Registreer voor een profiel en score.